Rotrosen J, Angrist B, Clark C, Gershon S, Halpers F S, Sachar E J
Am J Psychiatry. 1978 Aug;135(8):949-51. doi: 10.1176/ajp.135.8.949.
Prolactin levels were determined in plasma samples obtained before and after administration of apomorphine or L-dopa to otherwise unmedicated chronic schizophrenic patients or control subjects. Basal prolactin levels did not differ in these two groups. Suppression of prolactin levels after each dopamine agonist was highly significant. Suppression in schizophrenics was slightly less than in controls following apomorphine and slightly greater following L-dopa. The authors discuss the implications of these findings as well as the limitations of the prolactin regulatory system as an index of dopamine agonist sensitivity.
在未接受其他药物治疗的慢性精神分裂症患者或对照受试者中,测定了给予阿扑吗啡或左旋多巴前后采集的血浆样本中的催乳素水平。这两组的基础催乳素水平没有差异。每种多巴胺激动剂给药后催乳素水平的抑制作用非常显著。阿扑吗啡给药后,精神分裂症患者的催乳素水平抑制作用略低于对照组,而左旋多巴给药后则略高于对照组。作者讨论了这些发现的意义以及催乳素调节系统作为多巴胺激动剂敏感性指标的局限性。